ArticleJCO precision oncology2024
Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic Insights.
Shivani Handa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it